-
11041-250A pentacyclic triperpene isolated from birch tree bark that inhibits the SREBP-driven pathway of cholesterol and fatty acid biosynthesis 15-30 mg/kg/day decreases lipid levels and increases insulin sensitivity in mice fed a western-type diet and
-
11041-5A pentacyclic triperpene isolated from birch tree bark that inhibits the SREBP-driven pathway of cholesterol and fatty acid biosynthesis 15-30 mg/kg/day decreases lipid levels and increases insulin sensitivity in mice fed a western-type diet and
-
11041-500A pentacyclic triperpene isolated from birch tree bark that inhibits the SREBP-driven pathway of cholesterol and fatty acid biosynthesis 15-30 mg/kg/day decreases lipid levels and increases insulin sensitivity in mice fed a western-type diet and
-
B1979-10 mgBetulinic acid is a pentacyclic triterpene that exhibits antithrombotic, anti-atherosclerotic, antioxidative, anti-inflammatory, anti-angiogenic, and anticancer chemotherapeutic properties. Betulinic acid decreases expression of P-selectin and
-
B1979-250 mgBetulinic acid is a pentacyclic triterpene that exhibits antithrombotic, anti-atherosclerotic, antioxidative, anti-inflammatory, anti-angiogenic, and anticancer chemotherapeutic properties. Betulinic acid decreases expression of P-selectin and
-
B1979-50 mgBetulinic acid is a pentacyclic triterpene that exhibits antithrombotic, anti-atherosclerotic, antioxidative, anti-inflammatory, anti-angiogenic, and anticancer chemotherapeutic properties. Betulinic acid decreases expression of P-selectin and
-
11686-100An agonist of the bile acid receptor TGR5 (EC50 = 1 µM) and blocks fatty liver development in cells and mice given ethanol reduces NF-&kappaB signaling and expression of miR-33 in LPS-treated macrophages, increasing levels of ABCA1 inhibits
-
11686-250An agonist of the bile acid receptor TGR5 (EC50 = 1 µM) and blocks fatty liver development in cells and mice given ethanol reduces NF-&kappaB signaling and expression of miR-33 in LPS-treated macrophages, increasing levels of ABCA1 inhibits
-
11686-50An agonist of the bile acid receptor TGR5 (EC50 = 1 µM) and blocks fatty liver development in cells and mice given ethanol reduces NF-&kappaB signaling and expression of miR-33 in LPS-treated macrophages, increasing levels of ABCA1 inhibits
-
11686-500An agonist of the bile acid receptor TGR5 (EC50 = 1 µM) and blocks fatty liver development in cells and mice given ethanol reduces NF-&kappaB signaling and expression of miR-33 in LPS-treated macrophages, increasing levels of ABCA1 inhibits
-
B1992-100 mgBexarotene is a retinoid compound that binds and activates retinoid X receptors (RXRs) and is approved to treat cutaneous T cell lymphoma. Bexarotene displays a wide variety of beneficial activities, such as anticancer chemotherapeutic,
-
B1992-250 mgBexarotene is a retinoid compound that binds and activates retinoid X receptors (RXRs) and is approved to treat cutaneous T cell lymphoma. Bexarotene displays a wide variety of beneficial activities, such as anticancer chemotherapeutic,